Homology Medicines, Inc. Human Resources Contracts & Agreements
36 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Compensation Agreements (4)
- Consulting Agreements (3)
- Employment Agreements (22)
- Employment Agreement between Q32 Bio Inc. and Shelia Violette, dated March 25, 2024 (Filed With SEC on March 27, 2024)
- Employment Agreement between Q32 Bio Inc. and Jason Campagna, dated March 25, 2024 (Filed With SEC on March 27, 2024)
- Employment Agreement between Q32 Bio Inc. and Lee Kalowski, dated March 25, 2024 (Filed With SEC on March 27, 2024)
- Employment Agreement between Q32 Bio Inc. and Jodie Morrison, dated March 25, 2024 (Filed With SEC on March 27, 2024)
- Q32 Bio Inc. Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 27, 2024)
- Q32 Bio Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 27, 2024)
- Q32 Bio Inc. 2024 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on March 27, 2024)
- Q32 Bio Inc. 2017 Stock Incentive Plan, and form of award agreements thereunder (Filed With SEC on March 27, 2024)
- Consulting Agreement, dated November 17, 2023, by and between Homology Medicines, Inc. and W. Bradford Smith (Filed With SEC on December 18, 2023)
- Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and Charles Michaud, Jr (Filed With SEC on December 18, 2023)
- Amended and Restated Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and Paul Alloway, Ph.D (Filed With SEC on December 18, 2023)
- Consulting Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and W. Bradford Smith (Filed With SEC on November 16, 2023)
- Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and Charles Michaud, Jr (Filed With SEC on November 16, 2023)
- Amended and Restated Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and Paul Alloway, Ph.D (Filed With SEC on November 16, 2023)
- Second Amendment to Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and W. Bradford Smith (Filed With SEC on November 16, 2023)
- Amendment to Amended and Restated Employment Agreement, dated November 16, 2023, by and between Homology Medicines, Inc. and Albert Seymour, Ph.D (Filed With SEC on November 16, 2023)
- Amendment to Employment Agreement, dated as of September 6, 2022, between Homology Medicines, Inc. and Michael Blum (Filed With SEC on November 10, 2022)
- Amendment to Employment Agreement, dated as of September 6, 2022, between Homology Medicines, Inc. and Paul G. Alloway, Ph.D (Filed With SEC on November 10, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on November 10, 2022)
- Amendment to Employment Agreement, dated as of September 6, 2022, between Homology Medicines, Inc. and W. Bradford Smith (Filed With SEC on September 8, 2022)
- Consulting Agreement, dated as of September 6, 2022, between Homology Medicines, Inc. and Arthur O. Tzianabos, Ph.D (Filed With SEC on September 8, 2022)
- Amended and Restated Employment Agreement, dated as of April 21, 2022, between Homology Medicines, Inc. and Albert Seymour, Ph.D (Filed With SEC on April 21, 2022)
- Employment Agreement, dated September 1, 2021, by and between Homology Medicines, Inc. and Michael Blum (Filed With SEC on March 23, 2022)
- Employment Agreement, dated March 18 2020, by and between Homology Medicines, Inc. and Paul Alloway, Ph.D (Filed With SEC on March 23, 2022)
- 2018 Incentive Award Plan, and forms of awards thereunder (Filed With SEC on March 11, 2021)
- Employment Agreement, November 12, 2019, by and between Homology Medicines, Inc. and Gabriel M. Cohn, M.D (Filed With SEC on March 12, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on March 12, 2020)
- Employment Agreement, dated April 2, 2018, by and between Homology Medicines, Inc. and Tim Kelly (Filed With SEC on March 12, 2019)
- Employment Agreement, by and between the Registrant and Arthur Tzianabos, Ph.D. (to be effective upon the closing of this offering) (Filed With SEC on March 19, 2018)
- Employment Agreement, by and between the Registrant and Bradford Smith (to be effective upon the closing of this offering) (Filed With SEC on March 19, 2018)
- Employment Agreement, by and between the Registrant and Albert Seymour (to be effective upon the closing of this offering) (Filed With SEC on March 19, 2018)
- Employment Agreement, by and between the Registrant and Siyamak (Sam) Rasty (to be effective upon the closing of this offering) (Filed With SEC on March 19, 2018)
- Non-Employee Director Compensation Program (Filed With SEC on March 19, 2018)
- 2018 Incentive Award Plan and form of option agreements thereunder (Filed With SEC on March 19, 2018)
- 2015 Stock Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on March 19, 2018)
- 2015 Stock Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on March 2, 2018)